FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis. Issue 4 (8th August 2016)

• Record Type: Journal Article
• Authors: Taylor, Steven L; Woodman, Richard J; Chen, Alice CH; Burr, Lucy D; Gordon, David L; McGuckin, Michael A; Wesselingh, Steve; Rogers, Geraint B
• Is Part Of: Thorax. Volume 72:Issue 4(2017)
• Page Start: 304
• Page End: 310
• Publication Date: 2016-08-08
• Subjects: Bronchiectasis -- Bacterial Infection -- Viral infection; Chest -- Diseases -- Periodicals; Thorax; Chest -- Diseases; Periodicals; Periodicals; 617.54
• DOI: 10.1136/thoraxjnl-2016-208775
• Languages: English
• ISSNs: 0040-6376

Abstract

Abstract : Objective: To assess whether FUT2 ( secretor ) genotype affects disease severity and airway infection in patients with non-cystic fibrosis bronchiectasis. Participants: Induced sputum samples were obtained from 112 adult patients with high-resolution CT scan-proven bronchiectasis and at least two exacerbations in the previous year, as part of an unrelated randomised control trial. Outcome measures: Presence of null FUT2 polymorphisms were determined by gene sequencing and verified by endobronchial biopsy histochemical staining. Outcome measures were FEV1 % predicted, exacerbation frequency, and bacterial, fungal and viral components of the microbiota (measured by culture independent approaches). Results: Patients were grouped by FUT2 loss-of-function genotype; categorised as non-secretors (n=27, sese ), heterozygous secretors (n=54, Sese ) or homozygous secretors (n=31, SeSe ). FEV1 % was significantly lower in SeSe patients compared with sese patients (mean 61.6 (SD 20.0) vs 74.5 (18.0); p=0.023). Exacerbation frequency was significantly higher in SeSe (mean count 5.77) compared with sese (4.07; p=0.004) and Sese (4.63; p=0.026) genotypes. The time until first exacerbation was significantly shorter in SeSe compared with Sese (HR=0.571 (95% CI 0.343 to 0.950); p=0.031), with a similar trend for sese patients (HR=0.577 (0.311 to 1.07); p=0.081). sese had a significantly reduced frequency of Pseudomonas aeruginosa -dominated airway infection (8.7%) compared with Sese (31%; p=0.042) and SeSe (36%; p=0.035). In contrast, fungal, viral and non-dominant bacterial components of the microbiome were not significantly different between FUT2 genotypes. Conclusions: FUT2 genotype in patients with non-cystic fibrosis bronchiectasis was significantly associated with disease outcomes, with homozygous secretors exhibiting lower lung function, higher exacerbation number and a higher frequency of P. aeruginosa -dominated infection. Trial registration number: ACTRN12609000578202 (anzctr.org.au); Pre-results.